A carregar...
Noninvasive Evaluation of CD20 Expression Using (64)Cu-Labeled F(ab′)(2) Fragments of Obinutuzumab in Lymphoma
CD20-overexpressed non-Hodgkin lymphoma typically indicates progressive malignancy. Obinutuzumab is a next-generation Food and Drug Administration–approved humanized monoclonal antibody that targets CD20. Previous studies with (89)Zr-labeled obinutuzumab have successfully imaged CD20 in vivo. Howeve...
Na minha lista:
| Publicado no: | J Nucl Med |
|---|---|
| Main Authors: | , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Society of Nuclear Medicine
2021
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8049347/ https://ncbi.nlm.nih.gov/pubmed/32826320 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2967/jnumed.120.246595 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|